Department of Surgery, Hanyang University College of Medicine, Seoul, Korea.
Division of Breast and Endocrine Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Cancer Res Treat. 2018 Jan;50(1):275-282. doi: 10.4143/crt.2017.041. Epub 2017 Apr 14.
We evaluated the effect of positive superficial and/or deep margin status on local recurrence (LR) in invasive breast cancer treated with breast-conserving surgery (BCS) followed by radiotherapy.
In total, 3,403 stage 1 and 2 invasive breast cancer patients treated with BCS followed by radiotherapy from January 2000 to December 2008 were included in this study. These patients were divided into three groups according to margin status: clear resection margin status for all sections (group 1, n=3,195); positive margin status in superficial and/or deep sections (group 2, n=121); and positive peripheral parenchymal margin regardless of superficial and/or deep margin involvement (group 3, n=87). The LR-free survival between these three groups was compared and the prognostic role of margin status was analyzed.
Across all groups, age, tumor size, nodal status, and human epidermal growth factor receptor 2 status did not significantly differ. High grade, positive extensive intraductal component, hormone receptor positivity, hormone therapy received, and chemotherapy not received were more prevalent in groups 2 and 3 than in group 1. Five-year LR rates in groups 1, 2, and 3 were 1.9%, 1.7%, and 7.7%, respectively. Multivariate analysis revealed that group 3 was a significant predictor for LR (hazard ratio [HR], 4.78; p < 0.001), but that positive superficial and/or deep margin was not (HR, 0.66; p=0.57).
Superficial and/or deep margin involvement following BCS is not an important predictor for LR.
我们评估了保乳手术后(BCS)加放疗治疗的浸润性乳腺癌中阳性切缘(包括浅部和/或深部)对局部复发(LR)的影响。
本研究共纳入 2000 年 1 月至 2008 年 12 月期间接受 BCS 加放疗治疗的 3403 例 1 期和 2 期浸润性乳腺癌患者。根据切缘状态将这些患者分为三组:所有部位切缘均阴性(组 1,n=3195);浅部和/或深部切缘阳性(组 2,n=121);不论浅部和/或深部切缘是否阳性,周边实质切缘阳性(组 3,n=87)。比较三组间的 LR 无复发生存率,并分析切缘状态的预后作用。
在所有组中,年龄、肿瘤大小、淋巴结状态和人表皮生长因子受体 2 状态均无显著差异。高级别、阳性广泛导管内成分、激素受体阳性、接受激素治疗、未接受化疗在组 2 和组 3 中更为常见。组 1、组 2 和组 3 的 5 年 LR 率分别为 1.9%、1.7%和 7.7%。多因素分析显示,组 3 是 LR 的显著预测因素(风险比[HR],4.78;p<0.001),而浅部和/或深部切缘阳性不是(HR,0.66;p=0.57)。
BCS 后浅部和/或深部切缘受累不是 LR 的重要预测因素。